In a landmark move for public health, California, Oregon, and Washington announce a unified 'West Coast Pact' to independently review COVID-19 vaccines, prioritising safety and science over political pressure.
The CEO of Pfizer has alleged that former President Donald Trump directly suggested he should be awarded a Nobel Prize for his role in the rapid development of the COVID-19 vaccine, a revelation that has sent shockwaves through political and scientific ci
Podcast titan Joe Rogan ignites a fierce debate by citing controversial research connecting widely prescribed antidepressants to the epidemic of mass shootings. This investigation delves into the science and the silenced studies.
Uganda has inaugurated Africa's first major mRNA vaccine facility, a historic step towards medical self-reliance, combating diseases from COVID-19 to HIV, and reducing the continent's dependency on foreign pharmaceuticals.
US Presidential candidate Robert F. Kennedy Jr. launches a scathing attack on the CDC, accusing it of corruption and being a 'captured agency' of the pharmaceutical industry in a bombshell op-ed.
A nationwide manhunt is underway for a woman allegedly selling fake diabetes and weight-loss medications online. Authorities warn of severe health risks from counterfeit semaglutide injections.
In a fiery debate revelation, Donald Trump accuses pharmaceutical giants of a COVID-19 cover-up, vowing to force transparency on the pandemic's origins if re-elected. RFK Jr. backs the claim, igniting a new political firestorm.
A groundbreaking new hypertension drug, Baxdrostat, developed by AstraZeneca, has demonstrated remarkable success in clinical trials, potentially offering new hope for millions with treatment-resistant high blood pressure in the UK.
Former President Trump's proposed tariffs could severely restrict UK supplies and drastically increase prices for diabetes and weight-management medications like Ozempic, Wegovy, and Mounjaro, creating a new healthcare crisis.
Eli Lilly suspends shipments of obesity drug Mounjaro to the UK, triggering a major price surge and leaving thousands of patients in limbo amid supply chain restructuring.
Health Secretary Wes Streeting takes hardline stance in crucial NHS drug pricing negotiations with pharmaceutical giants, demanding better value for taxpayers while facing industry resistance.
A potential second Trump presidency could trigger massive price hikes for life-changing diabetes and obesity medications due to proposed import tariffs, putting essential treatments at risk for millions of Britons.
Health Secretary Wes Streeting confronts major pharmaceutical firms, demanding transparency and fair pricing in the NHS's voluntary rebate scheme, which recouped £1.4bn last year.
An explosive investigation reveals how pharmaceutical giant Novartis leveraged a WHO-led initiative to push its expensive cancer drug in Nigeria and Kenya, raising serious ethical concerns about Big Pharma's role in public health.
The cost of diabetes and weight-loss drugs Mounjaro and Ozempic has surged, sparking concerns over affordability and market competition. Experts weigh in on the implications.
Popular diabetes and weight-loss drugs Ozempic and Mounjaro face price hikes as Trump-era tariffs on Chinese imports take effect. Experts warn of potential shortages and financial strain on patients.
Pharmaceutical giant Eli Lilly announces a significant price increase for its diabetes and weight-loss drug Mounjaro in the UK, sparking concerns over affordability and access.
Former Florida Attorney General Pam Bondi faces ethics complaints for allegedly lobbying the Justice Department on behalf of a pharmaceutical company while serving on a federal drug enforcement board.
A pharmaceutical executive faces charges after a horrific wrong-way collision claimed the life of a former Olympic swimmer. The shocking incident has sent shockwaves through the community.
The pharmaceutical giant behind Mounjaro unveils an ambitious initiative to combat obesity in the UK, offering hope for millions struggling with weight-related health issues.
Pharmaceutical giant Eli Lilly is developing an oral weight loss drug that may compete with injectable treatments like Wegovy. Early trials show promising results, potentially offering a more convenient alternative for patients.
Delhi authorities have busted a massive counterfeit drug operation, with fake versions of Johnson & Johnson and GSK products seized. The racket poses serious health risks to consumers.
The US Food and Drug Administration (FDA) has approved a new Alzheimer's treatment, sparking debate over its efficacy and high cost while offering hope to millions.
Shares in major European pharmaceutical firms plummet as investors react to potential US tariffs, sparking market volatility and sector-wide uncertainty.
Sales of Novo Nordisk's blockbuster diabetes medications, including Ozempic, have dropped unexpectedly. Experts weigh in on the causes and future implications.
Former US President Donald Trump has floated the idea of imposing tariffs on imported pharmaceuticals, a move that could significantly impact the UK's healthcare sector and drug prices.
Former President Donald Trump’s controversial proposal to slash drug prices has reignited tensions with pharmaceutical giants. Critics warn of risks to innovation, while advocates hail it as a win for patients.
Former Chancellor George Osborne urges the UK to embrace cryptocurrency innovation or risk falling behind in the financial revolution.
The UK's Online Safety Act has ignited fierce debates between tech giants and policymakers on both sides of the Atlantic, with critics warning of threats to free speech while supporters champion user protection.
The UK Supreme Court has delivered a major blow to the Financial Conduct Authority (FCA) in a pivotal insurance dispute, reshaping policy interpretation for business interruption claims.